4-(4-{3-[4-(3-Chloro-4-fluoro-phenylamino)-6-methoxy-quinazolin-7-yloxy]-propoxy}-phenyl)-[1,2]dithiole-3-thione

ID: ALA4799549

Chembl Id: CHEMBL4799549

PubChem CID: 162677073

Max Phase: Preclinical

Molecular Formula: C27H21ClFN3O3S3

Molecular Weight: 586.14

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCOc1ccc(-c2cssc2=S)cc1

Standard InChI:  InChI=1S/C27H21ClFN3O3S3/c1-33-24-12-19-23(30-15-31-26(19)32-17-5-8-22(29)21(28)11-17)13-25(24)35-10-2-9-34-18-6-3-16(4-7-18)20-14-37-38-27(20)36/h3-8,11-15H,2,9-10H2,1H3,(H,30,31,32)

Standard InChI Key:  CTIUWYMIJLMPST-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4799549

    ---

Associated Targets(Human)

EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Egfr Epidermal growth factor receptor erbB1 (106 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 586.14Molecular Weight (Monoisotopic): 585.0418AlogP: 8.54#Rotatable Bonds: 10
Polar Surface Area: 65.50Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 4.64CX LogP: 7.36CX LogD: 7.36
Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.10Np Likeness Score: -1.10

References

1. Zheng YG,Zhang WQ,Meng L,Wu XQ,Zhang L,An L,Li CL,Gao CY,Xu L,Liu Y.  (2020)  Design, synthesis and biological evaluation of 4-aniline quinazoline derivatives conjugated with hydrogen sulfide (HS) donors as potent EGFR inhibitors against L858R resistance mutation.,  202  [PMID:32619886] [10.1016/j.ejmech.2020.112522]

Source